US stocks finished the first trading day of November mixed, with Big Tech names like Amazon (AMZN) and Nvidia (NVDA) rising ...
Stocks finished higher Friday as Amazon's strong quarterly results boosted the Nasdaq, with major indexes ending the week and ...
Amazon’s $38B AI deal and Palantir’s after-hours forecast lift tech stocks. Nasdaq leads, but Fed uncertainty and narrow ...
Bitcoin (CRYPTO: BTC) is posting substantial gains in a day of rebound trading for the broader crypto market. The cryptocurrency's token price had risen 2% over the previous 24 hours of trading, as of ...
Shares of Quantum Computing Inc. (NASDAQ: QUBT) are jumping on Monday, up 11% as of 2:23 p.m. ET. The spike comes as the S&P 500 (SNPINDEX: ^GSPC) and the Nasdaq Composite (NASDAQINDEX: ^IXIC) are ...
Lucid Capital initiated coverage on Applied Digital stock today with a buy rating. It set a one-year price target of $44 per share on the stock. Applied Digital (NASDAQ: APLD) stock is climbing ...
Most investors should own stocks. Most investors should also own crypto. The exact mix of these assets is up to you, but there are a few good approaches to consider. 10 stocks we like better than ...
It reported some highly encouraging news about its leading drug candidate. Cidara announced before market open that the U.S. Food and Drug Administration (FDA) has granted the healthcare company's ...
It seems the tech titan's latest product is striking a chord with consumers. One of those Apple reports came from researcher Counterpoint, which wrote that the company's latest iPhone model, the 17, ...
The major stock indexes were mixed on Monday, at the outset of another busy week of quarterly earnings reports and the release of key private sector employment data.
A large, veteran enterprise in the healthcare sector is apparently interested in acquiring it. Protagonist is well known to Johnson & Johnson, as the two companies collaborate on the development of a ...
Q3 2025 Earnings Call Transcript October 28, 2025 Operator: Thank you for standing by. Welcome to the Kiniksa Pharmaceuticals ...